Drug Shortage Report for FLAGYSTATIN

Last updated on 2024-01-30 History
Report ID 215796
Drug Identification Number 01926829
Brand name FLAGYSTATIN
Common or Proper name Flagystatin Ovules
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) NYSTATIN METRONIDAZOLE
Strength(s) 100000UNIT 500MG
Dosage form(s) OVULE SUPPOSITORY
Route of administration VAGINAL VAGINAL
Packaging size 10
ATC code G01AA
ATC description ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-01-10
Estimated end date 2024-02-09
Actual end date 2024-01-29
Shortage status Resolved
Updated date 2024-01-30
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-01-30 English Compare
v4 2024-01-29 French Compare
v3 2024-01-29 English Compare
v2 2024-01-12 French Compare
v1 2024-01-12 English Compare

Showing 1 to 5 of 5